<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 178 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page177.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=178">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 178 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 178</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=178"><img src="../thumb/178.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Blood and Haemopoeitic - 8.6                                                   2020-04 / 145
       room temp. bef.inj. init.treatm.und. supervis.of a doctor.  Warnings and special precautions: Risk/ benef. eval.reqd.bef.  (200 mg Fe/inj.) 1 ml test dos.to be inj. slow.over per.of 1-2 mins. Bal.
       Admin.SC/IV accord.to clinic.pref. Monit.Hb every 2wks.till stabi-  use in pregn., ther.to be confin. to 2  & 3  trimest.if need., enhanc.  of init.dos.may be giv.if no adverse effs.with.15  mins.of compl.test
                                                    nd
                                                      rd
       lis.& periodic.thereaft., SC inj can be admin.in abdom./arm/thigh,   risk with known allerg./sev.asthma hist./eczema or atop. allerg./im-  dos. Dos.calculat: Adults incl.elderly: Tot. cumulativ.dos.determ.
       treatm.norm.long term. If dos.miss.admin.miss.dos.ASAP & restart.   mun.& inflamm.condits., full resuscitat. facilit.to be avail.in case of   by Hb lev.& bm. Indiv.dos.& dos. sched. See prod.lit.for calc.of tot.Fe
       at prescrib.dos.freq.         poss. anaphylact. reacts., monit.pts.dur.admin.& at least 30 mins.  defic., numb. of amps.to be admin.& dilut.criteria. Tot. sngl. dos.not
       Pts.curr.NOT treat.with ESA:   aft.each inj., ther.to be stop.immed.in case of intol.signs/hypersens.,   to exceed 200 mg Fe giv.not more than 3x/wk. Admin.to be split if
       Pts.not on dialys.: Recomm.start.dos: 1,2 µg/kg bw once every   hypotens.episod. with rapid infus., oral Fe ther.not to be start.earl.   tot.necess.dos. exceeds max.allow.sngl.dos.
       mnth. as a sngl.              than 5 days aft.last inj.    Contraindications: Anaem.not caus.by Fe defic. (e.g.haemolyt.
       SC inj. Alternativ.a start.dos. of 0,6 µg/kg bw may be admin.once   Drug interactions: Concom.oral Fe absorpt.reduc.  anaem.), no adeq.studies for use in childr., safety in porphyr./lactat.
                                                                                st
       every 2 wks.as sngl.IV/SC inj.  See also MDR page 459.     not est., concom. oral Fe preps., 1  trimest.of pregn., mix./simultan.
       Pts.on dialys: Recomm.start.dos: 0,6 µg/kg bw once every 2 wks.as   NPLATE, Amgen &  admin.of other meds., SC/IM admin., tot.dos. infus., Fe storage dis.
       sngl. IV/SC inj.to incr. Hb to great.than 11 g/dL. Dos.may be incr.by   (iron overl.e.g. haemochromatos./ haemosideros.), disturbs.in iron uti-
       approx. 25% of prev.dos.if rate of Hb rise is less than 1,0 g/dL over a   Romiplostim  lisat., clinic./biochem.liv.damage evid., infectious hepatit., ac./chron.
                                     Indications: Adult chron.immune (idiopath.) thrombocytopen.pur-
       mnth. Furth.incr.of approx. 25% poss.at mnthly.interv.till indiv.target   infect., asthma/ eczema/other allerg.disords./anaphylact.react. hist.
       Hb lev.obt. If Hb rise &gt; 2 g/dL in 1 mnth.or Hb lev.incr.rapid (&gt;1 g/dL   pura (ITP) in splenectomis.pts refract.to other treatm.(e.g. corticos-  Side effects: Tachycard., palpitat., hypotens.& collapse, GI dis-
                                     ter., immunoglob.), 2nd line treatm.for adult non-splenectomis.pts.
       in any 2-wk per.) reduc.dos.by approx. 25% or more as need.to re-  turbs., fev., shiver., flush., chest pain & tightn., inj.site disords., fatig.,
       duc.rapid respons. Interrupt. ther if Hb lev. &gt;11 g/dL unt.Hb lev.falls   where surg.contra.indicat.  asthen., malaise, hyperhidros., anaphylact./anaphylactoid reacts.,
                                     (S4) POWD.FOR SOL.FOR INJ, 45/8.2/0175. 250 µg/0,5 ml
       below 11 g/dL & then restart.with approx.50 % of prev. admin.dos.  periph.oed., angioed., arthralg., reduc. consciousn.lev., lighthead.
       Pts.treat once every 2 wks.whose Hb conc.is &gt;11 g/dL may receive   714613-001: 250 µg, single vial, R7 095,12  feel., confus., musc. cramps, myalg., joint swell., back pain, trans.
                                     Dosage: Treatm.to remain under supervis.of practition. exper.in
       MIRCERA admin.1x/mnth. using the dos.equal to 2x the prev.once   treatm.of haematolog.dis. Do not use NaCl/bacteriostat.water for   taste pervers.esp.metall.taste, headache, dizzin., paraesthes., bron-
       every 2 wks dos. Do not adjust dos.more often than once a mnth.  reconstit., do not shake/vigour.agit.vial.  chosp., dyspn., skin reacts.
       Pts.curr.treat. with an epoetin: Convert to once a mnth. or once   Admin.1 x wk. as SC inject.  Special precautions: Cons.benef.vs risk in 2/3  trimest.of pregn.
                                                                                       rd
       every 2 wks.as sngl.IV/SC inj. Admin. 1  inj. at time sched.for prev.  Init.dos.: 1 µg/kg bas.on act.body weight.  admin.to women with sev.Fe defic. anaem.where there is an inabil.
                        st
       epoetin. Bas. start.dos.on prev.calc.wkly.epoetin dos.at time of sub-  Dos.adjustm.: Incr.1x wk.dos.in 1 µg increm.until pt.achiev.platel.  to absorb/ tol.adeq.amnts of oral Fe, avoid paraven.leak.at inj. site,
       stitut. as follow: &lt;8 000 units/wk: admin. 120 µg/mnth or 60 µg every   count ≥ 50 x 10 /l., assess.platel. count wkly.until stable count (≥   hypotens.episod.poss.if inj.admin.too rapidly, pts.with low bind.ca-
                                            9
       2 wks.8 000-16 000 units/wk: admin. 200 µg/mnth or 100 µg every 2   50 x 10 /l for at least 4 wks.without dos.adj.) achiev., assess. platel.   pacity &/folic acid defic. are at incr.risk of allerg./anaphylact.reacts.,
                                        9
       wks. &gt;16 000 units/wk: admin.360 µg/mnth or 180 µg every 2 wks.   counts monthly thereaft.  max.dly dos.of 200 mg not to be exceed., use for approv.indic.only.
       If dos.adjustm.reqd.to maint. target Hb conc.above 11 g/dL adjust   Platel.count &lt;50 x 10 /l: Incr.1x wk.dos.by 1 μg/kg. Platel.count   Warnings: CPR facilit.to be avail.for poss. allerg./ anaphylact.reacts.,
                                              9
       mnthly.dos.by approx.25%. If Hb rise great.than 2 g/dL in 1 mnth. or   &gt;200 x 10 /l for 2 consecut. wks: Decr.1x wk.dos.by 1 µg/kg. Pla-  discont.ther.in event of allerg. react.and init. est.resuscit.proced., pts.
                                         9
       Hb lev.incr.& approach.12 g/dL reduc.dos.by approx.25%. If Hb lev.  tel.count &gt;400x 10 /l: Do not admin.& contin. to assess. platel.count   with low Fe bind.capacit. &/fol.acid defic.partic.at risk of allerg. reacts.
                                             9
       contin.to incr.interupt. ther.until Hb.lev.starts to decr.when ther.may   wkly. Resum.with 1x wk. dos. reduc.by 1 µg /kg aft.count has fall.to
       be re-start.at dos.approx 25% below prev.admin.dos. Do not adjust   &lt;200 x 10 /l. Max.1x wk.dos: 10 µg/kg.  RECORMON, Roche
                                         9
       dos. more often than once a mnth.  Discontin.treatm.if platel.count does not incr.to lev.suffic.to avoid   Human erythropoietin (recombin.rhEPO).
       Contraindications: Uncontr.hypertens., pregn., lactat., pts.  clinic.import.bleed.aft.4 wks.of ther.at max.wkly.dos.of 10 µg/kg.  Indications: Replacem.of erythropoietin in transfus. depend.pts.with
       und.18 yrs.due to lack of safety & effic. data, anaem. assoc.with   Contra-indications: Hypersens.to E.coli, safety in pregn./lactat./  ren.anaem.requir.reg. haemodialys., symptomat.ren.anaem.treatm.in
       hepatit.C.                    ren.impairm./hepat.impairm not est., childr. &lt; 18 yrs.  non-dialysed pts.with chron.ren.fail., prev. prematurity anaem.in inft
       Side effects: Hypertens., thrombocytopen., pure red cell aplasia,   Side-effects: Infect.incl.influenza, loc.infect., nasopharyngit., multip.  less than 34 wks.& birth weight betw 750-1500 g, treatm.of symp-
       headache, hypertens. encephalopathy, maculo-papul.rash, Stev.-  myeloma, myelofibros., bld. & lymphat.syst.disords.incl.bone marrow   tomat. adult anaem in non-myeloid malign.receiv. chemother., incr.
       Johns. syndr./tox. epiderm.necrolys., vasc.access thrombos., hot   disord./ fail., thrombocytop., aplast.anaem., leukocytos., splenomeg.,   yield of autologous bld.donat.by pts. sched.for elect.surg.bal.against
       flush, thrombos., pulm.embol., hypersens., anaphylact.reacts.., slight   platel.count incr./abnorm., alcoh. intol., anorex., decr.appet., dehy-  incr.risk of thromboembol.events.
       decr.in platel. count.        drat., gout, insomn., depress., abnorm.dreams, headache, dizzin.,   (S4) PRE-FILL.SYR., A38/8.3/0499, 37/8.3/0567, 0568, 0569,
       Warnings and special precautions: Anti-erythropoietin antibod.  paraesthes., migraine, clonus, dysgeus., hypoaesthes., hypogeus.,   38/8.3/0500, 39/8.3/0105
       shown to cross react with erythropoietin stimulat.agents theref.do not   neuropathy periph., transv.sinus thrombos., conjunctiv.haemorrh.,   704632-001: 500 IU/pre-fill.syr., 4 syr., R250,33
       switch to Mircera if erythropoietin antibod.suspect./ confirm., para-  accommodat.disord., blindn., eye disord/prurit., incr.lacrimat., papil-  704772-001: 2 000 IU/pre-fill.syr., 6 syr., R1 003,10
       doxic.decr.in Hb & developm.of sev. anaem. assoc.with low reticuloc   loed., vis.disturbs., vertigo, MI, incr.heart rate, flush/, DVT, hypotens.,   704631-001: 4 000 IU/pre-fill.syr., 6.syr., R2 006,21
       counts should prompt discont.of treatm.& test.for anti-erythropoietin   periph. embol./ ischaem., phlebit., thrombophlebit. superfic, throm-  704630-001: 6 000 IU/pre-fill.syr., 6 syr., R2 947,11
       antibod., maint.Hb conc.should not exceed. the upper limit of target   bos., pulm.embol., cough, rhinorrh., dry throat, dyspn., nas.congest.,   705261-001: 10 000 IU/pre-fill.syr., 6 syr., R5 538,86
       Hb conc.recomm. in dosage in pts.with chron.kidn.dis., monit.BP bef.  painf.resp., GI disords. incl.dyspeps., constip., rect.haemorrh., breath   705751-002: 30 000 IU/pre-fill.syr., 1 syr., R3 352,30
       init.& dur.ther, may stimul.growth of any type of malign., safety &   odour, dysphag., GORD, haematochez., mouth haemorrh., stom.dis-  705751-001: 30 000 IU/pre-fill.syr., 4 syr., R13 409,21
                                                                                       st
       effic.not est.in haemoglobinopathies/ seiz./platelet lev.great. than   comf., stomatit., tooth discolour., port.vein thrombos., incr.transamin.,   Dosage: Admin.init.by experienc.physic. Admin. 1  dos.under medic.
          9
       500x10 /L, eval.Fe status & supplem.Fe ther. recomm.in all pts.with   prurit., ecchymosis, rash, alopec., photosens., acne, contact dermatit.,   supervis., As treatm.cannot be predict. Hb & platelet.monit.imperat.
       ser.ferritin values bel. 100 µg/L or transferr.saturat.bel.20%, chron.  dry skin, eczema, erythema, exfoliat./papul./prurit.rash, abnorm.hair   Anaem.pts.with chron.ren.fail: Admin.SC/ IV. IV admin.over 2
       bld. loss/ bone marr.fibros./sev.Al overload from ren. fail.treatm./folic   growth, prurigo, purpura, skin nodule, abnorm.skin odour, urticar.,   mins., for non-haemodialys. pts. SC admin. preferr. in order to avoid
       acid or Vit.B defic.& haemolysis may comprom.therapeut.effectiven.,   arthralg., myalg., extrem./back/ bone/shoulder/chest pain, musc.  punct.of periph. veins. Haemodialysis pts: Admin.SC or IV via the
       consid.poss. pure red cell aplas.(PRCA) if pt.has sudd.Hb drop assoc.  spasm/tightn./ weakn./ twitch., prot.urine, vag.haemorrh., fatig.,   arterio-venous fistula at at the end of dialysis over approx. 2 mins.
       with reticulocytopen.& anti-erythropoietin antibod.& all other poss.  periph.oed., asthen., pyrex., chills, inj.site react./ haemorrh., irritabil.,   Non-haemodialysed pts: SC admin. pref. In chron.kidn.dis target HB
       causes excl., discont.ther. & switch to other ESA if PRCA diagnos.  malaise, face oed., feel.hot/ jittery, incr.BP/bld.lact.dehydrogen./body   lev is 10-12 g/dl or determ.indiv.in pres.of hypertens./exist.CV, cer-
                                                                  ebrovasc/ periph.vasc.dis.
       MONOFER, Litha [P/S] &        temp., incr./ decr.weight, contus., thrombocytos., thrombocytop.aft.  Treatm.is div.into 2 phases.(ie. correct.& maint phase)
       Iron as iron(111) isomaltoside  cessat of treatm., incr.bone marr.reticul., immunogenic.  Correct.phase: SC admin: Init: 20 IU/kg bm 3x/wk, may be incr.
       Indications: Fe defic.when oral preps.ineffect./ cannot be used, clin-  Warnings and special precautions:. Eval.pt. periodic.& decid.con-  every 4 wks.by 20 IU/kg bm 3x/wk.if incr.of pack.cell vol.not adeq.
       ic.need to deliv.iron rapid. where diagn.confirm.by appropr.investigat.  tinuat.of treatm.on indiv.bas., thrombocytopen.likely to reoccur upon   (&lt;0,25 g/dl per wk).Wkly.dos.can be div.into dly dos.
       (S3) SOL FOR INJ/INFUS, 46/8.3/0166, 0167, 0168  discont.of treatm., incr.bleed.risk if ther.discont.in pres.of anticoags./  IV admin: Init 40 IU/kg bm 3x/wk. To achieve a pack.cell vol of
       722191-001: 100 mg/ml, 5x1 ml, R2 065,18  anti platel.agents, monit.pts.for a decr. platel.count & manag.medical.  betw.30-35%, the dos.may be rais. aft.1 mnth.to 80 IU/kg bm.3x/
                                     to avoid bleed.upon discont. of treatm., restart ITP treatm.accord.to
       722192-001: 500 mg/5 ml vial, 5x5 ml, R10 325,89           wk.furth increm.of 20 IU/kg 3x/wk.if need.at mnthly interv. Max.dos.
       722193-001: 1 000 mg/10 ml vial, 2x10 ml, R8 260,72  curr. treatm.guidelines.upon Nplate discontin., exam. for cellul.mor-  not to exceed 720 IU/kg bm/wk.
                                     phologic.abnorm.using periph. bld.smear & compl.bld.count prior to &
       Dosage: Admin.by staff & in facilit.equip.to manage anaphylact.  Maint.phase: To maint.target Hb value of approx. 10-12 g/dl the dos.
       reacts. Observe for at least 30 mins.follow.each inj. Keep numb.of   dur.treatm. recomm., discont.& exam.physic.if loss of effic./ abnorm.  is init.½ the prev.admin.amount in the correct.phase. Haematocrit lev-
                                     periph.bld.smear observ & consid.bone marr.biopsy with appropr.
       sngl.IV admin. to a minimum. Admin.test dos.corresp.to 25 mg Fe or   el of 35 % should not be exceed. Subseq.adjust.dos.at 2-4 wks indiv.
                  st
       equal to 0,25 ml sol. bef.1  Monofer dos.giv. Remain. dos.admin.if no   stain.for reticulin., if effic.maint.& abnorm.bld.smear observ.consid.  Admin.SC dos.as wkly dos.given poss.as sngl. dos/div dos.3 or 7x/wk.,
                                     risk vs benef.& alternat.ITP options, not for treatm.of thrombocytop.
       adverse react.aft.60 min. Admin. only with 0,9% NaCl as dil.for infus.   Switch pts.stable on once wkly dos.regim. to once every 2 wk.admin.
       Tot. cumulat.dos.determin.by Hb lev.& bm. Indiv. accord. to Fe defic.   due to myelodysplast.syndr./any other cause of thrombocytopen.other   Prev.anaem.of prematurity: Admin.SC 250 IU/kg bm/3x/wk.x6
       See prod.lit.for dos.calculat. Contin. ther.may be reqd.to maint.Hb targ.  than ITP, loss of respon./fail.to maint.platel.respon.within recomm.   wks. Start treatm.ASAP pref.at day 3 of life. Infts.already transfus.
                                     dos.range should prompt search for causat. fact.incl.immunogenic.&
       lev.& accept.other Fe paramet.limit. IV bolus inj: Admin. up to 500 mg   at start of treatm.are not likely to benef.as much as untransfus. infts.
       up to 3x/wk at up to 250 mg Fe/min. undil./dilut.in max.20 ml 0,9%   incr.bone marrow reticul., monit.red & white bld.cell paramet.when   Symptomat.anaem.in Ca pts: Admin.SC. Admin. wkly.dos.as one
                                     appropr., monit.platel.count when combin.Nplate with other medic.
       NaCl. IV drip infus: Cumul.Fe dos.reqd.may be admin.in sngl.infus.  inj/wk or can be in div.dos.3-7 sngl. times/wk. Recomm.init.dos.
       up to 20 mg iron/kg bm or as wkly infus. Dos.to be split in 2 dos.with   prod.for ITP treatm.to avoid platel. counts outside of recomm.range,   30 000 IU/wk. (correspond.to approx.450 IU/kg bm/ wk). Treatm. indic.
                                     elderly, reduc./ discont.concom.cortioster./danazol & azathioprine,
       interv.of at least 1 wk if cumulat. Fe dos.exceeds 20 mg iron/kg bm.   if Hb is &lt;11 g/dl & not exceed 12 g/dl. If Hb value incr.by at least 1 g/
       Recomm. where poss.to admin.20 mg iron/kg bm in 1  admin. Sec-  reproduct.toxic.in anim.stud.  dl aft.4 wks.ther.cont. curr. dos. Consid.doubl.dos.if Hb val.not incr.by
                             st
                                     See also MDR page 148.
       ond admin.may be giv.aft.lab. results recd. Admin.dos.up to 1000 mg   at least 1 g/ dl aft.4 wks. If Hb value not incr.by at least 1 g/dl aft.8
       over 15 mins. or more & dos.exceed.1000 mg over 30 mins. or more.   RAUTEVENE, Actor Pharma [P/S]  wks.ther.respons.unlikely & discont. Cont.ther.for at least 4 wks.aft.
       Admin.undilut./dilut.in max. 500 ml 0,9% NaCl.  Iron(III)-hydroxide sucrose complex.  end of chemother. Max.dos.not to exceed 60 000 IU/wk. Once thera-
       Direct.inj.into venous dialys.limb: Same as for IV bolus inj.  Indications: Sev.adult Fe defic.in pts.not tol./ respond. to oral   peutic object.achiev.reduc.dos by 25-50% to maint.Hb lev. If necess.
       Contraindications: Known ser.hypersens.to other parent.Fe prod.,   Fe.when confirm. by appropr. investigat.  do furth.dos.reduct. to ensure Hb lev not exceed 12 g/dl. If Hb rise
       non-Fe defic.anaem., Fe overload/Fe utilisat.disturbs., decompens.   (S3) INJ, 46/8.3/0849. 100 mg/5 ml  great. than 2 g/dl in 4 wks.reduc.dos.by 25-50%
       liv. cirrhos. & hepatit., ac./chron.infect., meds. hypersens. incl.Fe   719989-001: 5x5 ml amps, R614,01  Incr.yield of donat.autologous bld: Admin. reconstit. sol.IV over
       mono-disaccharid.compl.& dextran, Rh arthrit.with act.inflamm.S&S,   Dosage: IV admin.only by slow IV inj./IV drip infus./ into venous limb   approx.2 mins./SC. Admin. 2x/wk.over 4 wks. When pts.condit.allows
       ac.ren. fail., lactat., childr.& adolesc.und.18 yrs.as insuffic. data on   of dialyser in pts.receiv. haemodialys. Always admin.a test dos.of 1   bld. donat. (ie. PCV &gt; 33%) admin.Recormon at end of bld.donat. Dur.
       safety & effic., concom.with oral Fe preps., ongo.bacteraem., mix.  to 2,5 ml Rautevene (20-50 mg Fe) by chos.route bef. 1  therap. dos.   entire treatm.period PCV of 48% should not be exceed. Dos.is determ.
                                                           st
       with other agents.            Bal.of init.dos.may be giv.if no adverse react.occurs with.wait.per.  by surg.team for each indiv.pt.as funct.of the reqd.amnt.of pre-donat.
       Side effects: Bact./vir.infects.poss.exacerbat.by parent.Fe admin.,   of at least 15 min. aft.admin. Infus: 1 amp.dilut.in 100 ml NaCl im-  bld.& endogen. red.cell reserve. See manufact. lit.for full detail.
       ac.sev.anaphylact.reacts.incl. fatal., shiver., delay.somet.sev.reacts.up   med.prior to infus.(i.e.2 amps in 200 ml NaCl). 1  25 ml of sol.infus.  Contraindications: Childr.und.6 yrs.as clinic. exper. insuffic., uncontr.
                                                         st
       to 4 days aft. admin, arthralg., myalg., fev., Rh arthrit.joint pain exacer-  as test dos.over 15 min. Bal.of infus.to be giv.as foll.if no react.dur   hypertens., pregn., lactat., MI./ stroke/unstable ang.pect./DVT risk in
       bat., card.disords., haemolys., CNS effs., blurr.vis., seiz., dizzin., trem.,   this time: 100 mg Fe (5 ml Rautevene) in at least 15 min. & 200 mg   mnth preced.treatm.for incr.yield in autolog.bld.indicat.
       fatig., headache, paraesthes., deafn., dyspn., chest pain, GI disturbs.,   Fe (10 ml Rautevene) in at least 30 mins. IV inj: Admin.slow.at rate   Side effects: Incr.in BP/aggrav.of exist. hypertens. esp.in cases of
       skin/loc. reacts., sweat., flush., cramps, hypo-/hypertens., angioed.  of 1 ml undilut. sol./min. (5 min./amp.)not exceed.2 amps Rautevene   rapid PCV incr., hypertens. crisis with encephalopathy-like sympts. in</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page177.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page173.html">173</a>&nbsp;&nbsp;&nbsp;<a href="page174.html">174</a>&nbsp;&nbsp;&nbsp;<a href="page175.html">175</a>&nbsp;&nbsp;&nbsp;<a href="page176.html">176</a>&nbsp;&nbsp;&nbsp;<a href="page177.html">177</a>&nbsp;&nbsp;&nbsp;<a href="page178.html">178</a>&nbsp;&nbsp;&nbsp;<a href="page179.html">179</a>&nbsp;&nbsp;&nbsp;<a href="page180.html">180</a>&nbsp;&nbsp;&nbsp;<a href="page181.html">181</a>&nbsp;&nbsp;&nbsp;<a href="page182.html">182</a>&nbsp;&nbsp;&nbsp;<a href="page183.html">183</a>
             </td>
             <td width="35%"><a href="page179.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page179.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
